ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2026-32906

OpenClaw before 2026.5.12 contains a privilege escalation vulnerability in Slack plugin approvals that allows exec-authorized users to resolve plugin approvals through…

Published May 29, 2026 · catalog updated Jul 21, 2026 · the affected product

Check if you run it

No confirmed exploitation is on record for CVE-2026-32906. EPSS is 0.29%. Act only if a listed version of the affected product is installed.

Gaps on this record

  • No plain product name is stored. The page cannot tell you which product to check.
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Low2.3
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.29%
Remediation
Advisory link
Affected products
cpe openclaw/openclaw

OpenClaw before 2026.5.12 contains a privilege escalation vulnerability in Slack plugin approvals that allows exec-authorized users to resolve plugin approvals through the exec approver gate. Attackers with limited exec approval permissions can bypass intended approval splits to approve plugin actions outside operator configuration.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe openclaw/openclawversion unspecified

How to fix CVE-2026-32906

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-32906. EPSS is 0.29%. Act only if a listed version of the affected product is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-863: Incorrect Authorization. EPSS 0.29%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

Timeline

Detection, updates, and resolution for this record.

  1. May 29, 2026 · NIST NVD

    Detected

    OpenClaw before 2026.5.12 contains a privilege escalation vulnerability in Slack plugin approvals that allows exec-authorized users to resolve plugin approvals through the exec approver gate. Attackers with limited exec approval permissions can bypass intended approval splits to approve plugin actions outside operator configuration.

  2. Jul 21, 2026 · NIST NVD

    Updated

    OpenClaw before 2026.5.12 contains a privilege escalation vulnerability in Slack plugin approvals that allows exec-authorized users to resolve plugin approvals through the exec approver gate. Attackers with limited exec approval permissions can bypass intended approval splits to approve plugin actions outside operator configuration.

Sources

  • CVE.orgVulnerability recordCVE-2026-32906

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-32906

    30-day exploitation probability 0.3%

    first.org
  • NIST NVDVulnerability recordCVE-2026-32906

    OpenClaw before 2026.5.12 contains a privilege escalation vulnerability in Slack plugin approvals that allows exec-authorized users to resolve plugin approvals through the exec approver gate. Attackers with limited exec approval permissions can bypass intended approval splits to

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.